EUVIMEDEUVIMED entdecken
Crossref

Effect of combined sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonist therapy in patients with chronic kidney disease: a real-world analysis

Cheng-Wei Ho, Min-Hsiang Chuang, Vin-Cent Wu, Yu-Kuan Tu, Yea-Chwen Wu, Jui-Yi Chen

Kidney Research and Clinical Practice · 02.11.2026

DOI: 10.23876/j.krcp.26.241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, online erschienen am 02.11.2026. Verfasst von Cheng-Wei Ho und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Chi-Mei Medical Center, Tainan, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Chronic renal insufficiencyGlucagon-like peptide-1 receptor agonistsSodium-glucose transporter 2 inhibitors

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, Chi-Mei Medical Center, Tainan, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • NSARF (National Taiwan University Hospital Study Group of ARF) and TAIPAI (Taiwan Primary Aldosteronism Investigators), Taipei, Taiwan.
  • Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.

Zitieren

APA

Ho, C. W., Chuang, M. H., Wu, V. C., Tu, Y. K., Wu, Y. C., & Chen, J. Y. (2026). Effect of combined sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonist therapy in patients with chronic kidney disease: a real-world analysis. Kidney Research and Clinical Practice. https://doi.org/10.23876/j.krcp.26.241

Vancouver

Ho CW, Chuang MH, Wu VC, Tu YK, Wu YC, Chen JY. Effect of combined sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonist therapy in patients with chronic kidney disease: a real-world analysis. Kidney Research and Clinical Practice. 2026. doi:10.23876/j.krcp.26.241

BibTeX
@article{Ho2026,
  author = {Ho, Cheng-Wei and Chuang, Min-Hsiang and Wu, Vin-Cent and Tu, Yu-Kuan and Wu, Yea-Chwen and Chen, Jui-Yi},
  title = {Effect of combined sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonist therapy in patients with chronic kidney disease: a real-world analysis},
  journal = {Kidney Research and Clinical Practice},
  year = {2026},
  doi = {10.23876/j.krcp.26.241}
}
Kostenlos starten →